Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury

作     者：Ali Myatich Azizul Haque Christopher Sole Naren L.Banik Ali Myatich;Azizul Haque;Christopher Sole;Naren L.Banik

作者机构：Department of Microbiology and ImmunologyMedical University of South CarolinaCharlestonSCUSA Department of NeurosurgeryMedical University of South CarolinaCharlestonSCUSA Ralph H.Johnson Veterans Administration Medical CenterCharlestonSCUSA Department of Health and Human PerformanceThe CitadelCharlestonSCUSA 

出 版 物：《Neural Regeneration Research》 (中国神经再生研究（英文版）)

年 卷 期：2023年第18卷第5期

页      面：940-946页

核心收录：

学科分类：0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 10[医学] 

基　　金：supported in part by funding from the Veterans Administration (1IOBX001262, 1I01 BX004269) South Carolina State Spinal Cord Injury Research Fund (SCIRF-2015P-01, SCIRF-2015P-04, SCIRF-2015-I-01, SCIRF#2016 I-03, and SCIRF#2018 I-01)(to AH) supported in part by funding from the National Institutes of Health (1R21NS118393-01)(to AH) a Research Career Scientist award (#IK6BX005964) from the Department of veterans Affairs。 

主　　题：axonal damage clemastine myelination neuronal death oligodendrocytes skeletal muscle spinal cord injury 

摘      要：Spinal cord injuries affect nearly five to ten individuals per million every year. Spinal cord injury causes damage to the nerves, muscles, and the tissue surrounding the spinal cord. Depending on the severity, spinal injuries are linked to degeneration of axons and myelin, resulting in neuronal impairment and skeletal muscle weakness and atrophy. The protection of neurons and promotion of myelin regeneration during spinal cord injury is important for recovery of function following spinal cord injury. Current treatments have little to no effect on spinal cord injury and neurogenic muscle loss. Clemastine, an Food and Drug Administration-approved antihistamine drug, reduces inflammation, protects cells, promotes remyelination, and preserves myelin integrity. Recent clinical evidence suggests that clemastine can decrease the loss of axons after spinal cord injury, stimulating the differentiation of oligodendrocyte progenitor cells into mature oligodendrocytes that are capable of myelination. While clemastine can aid not only in the remyelination and preservation of myelin sheath integrity, it also protects neurons. However, its role in neurogenic muscle loss remains unclear. This review discusses the pathophysiology of spinal cord injury, and the role of clemastine in the protection of neurons, myelin, and axons as well as attenuation of skeletal muscle loss following spinal cord injury.